Home
>
National Drug Code (NDC)
>
KOMBIGLYZE
KOMBIGLYZE - 0003-4223-31 - (SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE)
Drug Information of KOMBIGLYZE
| Product NDC: | 0003-4223 |
| Proprietary Name: | KOMBIGLYZE |
| Non Proprietary Name: | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE |
| Active Ingredient(s): | 1000; 5 mg/1; mg/1 & nbsp; SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of KOMBIGLYZE
| Product NDC: | 0003-4223 |
| Labeler Name: | E.R. Squibb & Sons, L.L.C. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA200678 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101105 |
Package Information of KOMBIGLYZE
| Package NDC: | 0003-4223-31 |
| Package Description: | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0003-4223-31) |
NDC Information of KOMBIGLYZE
| NDC Code | 0003-4223-31 |
| Proprietary Name | KOMBIGLYZE |
| Package Description | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0003-4223-31) |
| Product NDC | 0003-4223 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20101105 |
| Marketing Category Name | NDA |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Substance Name | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE |
| Strength Number | 1000; 5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
